Impaired sensory nerve function and axon morphology in mice with diabetic neuropathy

Journal of Neurophysiology

Volumn 106, Issue 2, 2011, Pages 905-914

  Lennertz, Richard C ^a   Medler, Karen A ^a   Bain, James L ^a   Wright, Douglas E ^b   Stucky, Cheryl L ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

C fiber; Electron microscopy; Mechanotransduction; Sensory nerve; Skin nerve

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AXOPLASM; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FUNCTIONAL DISEASE; HYPOALGESIA; MALE; MECHANICAL STIMULATION; MORPHOLOGY; MOUSE; NERVE ENDING; NERVE FIBER; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SIGNAL TRANSDUCTION; SKIN NERVE; TACTILE DISCRIMINATION; THERMAL STIMULATION;

ANIMALS; AXONS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; MALE; MICE; MICE, INBRED C57BL; NEURAL CONDUCTION; RANDOM ALLOCATION; SENSATION; SENSORY RECEPTOR CELLS;

EID: 80051500527     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.01123.2010     Document Type: Article

References (48)

1. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 8: 29, 2010.
2. Calcutt NA, Freshwater JD, Mizisin AP. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47: 718-724, 2004.
3. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63, 1994.
4. Chen X, Levine JD. Hyper-responsivity in a subset of C-fiber nociceptors in a model of painful diabetic neuropathy in the rat. Neuroscience 102: 185-192, 2001.
5. Christianson J. Beneficial actions of neurotrophin treatment on diabetesinduced hypoalgesia in mice. Pain 4: 493-504, 2003.
6. Christianson JA, Ryals JM, Johnson MS, Dobrowsky RT, Wright DE. Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice. Neuroscience 145: 303-313, 2007.
7. Courteix C, Eschalier A, Lavarenne J. Streptozotocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53: 81-88, 1993.
8. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 329: 977-986, 1993.
9. Drel VR, Pacher P, Vareniuk I, Pavlov IA, Ilnytska O, Lyzogubov VV, Bell SR, Groves JT, Obrosova IG. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes. Int J Mol Med 20: 783-792, 2007.
10. Fedele D, Giugliano D. Peripheral diabetic neuropathy. Current recommendations and future prospects for its prevention and management. Drugs 54: 414-421, 1997.
11. Feldman EL, Russell JW, Sullivan KA, Golovoy D. New insights into the pathogenesis of diabetic neuropathy. Curr Opin Neurol 12: 553-563, 1999.
12. Greene DA, Stevens MJ, Feldman EL. Diabetic neuropathy: scope of the syndrome. Am J Med 107: 2S-8S, 1999.
13. Griffin JW, McArthur JC, Polydefkis M. Assessment of cutaneous innervation by skin biopsies. Curr Opin Neurol 14: 655-659, 2001.
14. Harati Y. Diabetic neuropathies: unanswered questions. Neurol Clin 25: 303-317, 2007.
15. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88, 1988.
16. Johnson MS, Ryals JM, Wright DE. Early loss of peptidergic intraepidermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathy. Pain 140: 35-47, 2008.
17. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47: 1042-1048, 1996.
18. Koltzenburg M, Stucky CL, Lewin GR. Receptive properties of mouse sensory neurons innervating hairy skin. J Neurophys 78: 1841-1850, 1997.
19. Kwan KY, Glazer JM, Corey DP, Rice FL, Stucky CL. TRPA1 modulates mechanotransduction in cutaneous sensory neurons. J Neurosci 29: 4808-4819, 2009.
20. Lauria G, Cornblath DR, Johansson O, McArthur JC, Mellgren SI, Nolano M, Rosenberg N, Sommer C. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 12: 747-758, 2005.
21. Lennertz RC, Tsunozaki M, Bautista DM, Stucky CL. Physiological basis of tingling paresthesia evoked by hydroxyl-alpha-sanshool. J Neurosci 30: 4353-4361, 2010.
22. Li F, Drel VR, Szabó C, Stevens MJ, Obrosova IG. Low-dose poly(ADPribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy. Diabetes 54: 1514-1522, 2005.
23. Love S, Cruz-Höfling MA, Duchen LW. Morphological abnormalities in myelinated nerve fibres caused by Leiurus, Centruroides and Phoneutria venoms and their prevention by tetrodotoxin. Q J Exp Physiol 71: 115-122, 1986.
24. Lumpkin EA, Caterina MJ. Mechanisms of sensory transduction in the skin. Nature 445: 858-865, 2007.
25. Maeda K, Fernyhough P, Tomlinson DR. Regenerating sensory neurones of diabetic rats express reduced levels of mRNA for GAP-43, gamma-preprotachykinin and the nerve growth factor receptors, trkA and p75NGFR. Mol Brain Res 37: 166-174, 1996.
26. Maricich SM, Wellnitz SA, Nelson AM, Lesniak DR, Gerling GJ, Lumpkin EA, Zoghbi HY. Merkel cells are essential for light-touch responses. Science 324: 1580-1582, 2009.
27. McCarthy BG, Hsieh ST, Stocks A, Hauer P, Macko C, Cornblath DR, Griffin JW, McArthur JC. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 45: 1848-1855, 1995.
28. Mohiuddin L, Fernyhough P, Tomlinson DR. Reduced levels of mRNA encoding endoskeletal and growth-associated proteins in sensory ganglia in experimental diabetes. Diabetes 44: 25-30, 1995.
29. Mohiuddin L, Tomlinson DR. Impaired molecular regenerative responses in sensory neurones of diabetic rats: gene expression changes in dorsal root ganglia after sciatic nerve crush. Diabetes 46: 2057-2062, 1997.
30. Myers RR, Powell HC. Galactose neuropathy: impact of chronic endoneurial edema on nerve blood flow. Ann Neurol 16: 587-594, 1984.
31. Obrosova I, Xu W, Lyzogubov VV, Ilnytska O, Mashtalir N, Vareniuk I, Pavlov IA, Zhang J, Slucher B, Drel VR. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. Free Radic Biol Med 44: 972-981, 2008.
32. Obrosova I. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeautics 6: 638-647, 2009.
33. Pertovaara A, Wei H, Kalmari J, Ruotsalainen M. Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in rat: modulation by nitecapone, a COMT inhibitor with antioxidant properties. Exp Neurol 167: 425-434, 2001.
34. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 [author's translation]. Diabete Metab 3: 97-107, 1977.
35. Powell HC, Myers RR. Schwann cell changes and demyelination in chronic galactose neuropathy. Muscle Nerve 6: 218-227, 1983.
36. Reeh PW. Sensory receptors in mammalian skin in an in vitro preparation. Neurosci Lett 66: 141-146, 1986.
37. Shun CT, Chang YC, Wu HP, Hsieh SC, Lin WM, Lin YH, Tai TY, Hsieh ST. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 127: 1593-1605, 2004.
38. Sima AA, Lattimer SA, Yagihashi S, Greene DA. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. J Clin Invest 77: 474-484, 1986.
39. Sima AA, Lorusso AC, Thibert P. Distal symmetric polyneuropathy in the spontaneously diabetic BB-wistar rat. An ultrastructural and teased fiber study. Acta Neuropathol 58: 39-47, 1982.
40. Stucky CL, DeChiara T, Lindsay RM, Yancopoulos GD, Koltzenburg M. Neurotrophin 4 is required for the survival of a subclass of hair follicle receptors. J Neurosci 18: 7040-7046, 1998.
41. Stucky CL, Koltzenburg M, Schneider M, Engle MG, Albers KM, Davis BM. Overexpression of nerve growth factor in skin selectively affects the survival and functional properties of nociceptors. J Neurosci 19: 8509-8516, 1999.
42. Suzuki Y, Sato J, Kawanishi M, Mizumura K. Lowered response threshold and increased responsiveness to mechanical stimulation of cutaneous nociceptive fibers in streptozotocin-diabetic rat skin in vitro-correlates of mechanical allodynia and hyperalgesia observed in the early stage of diabetes. Neurosci Res 43: 171-178, 2002.
43. Suzuki Y, Sato J, Kawanishi M, Mizumura K. Tissue glucose level modulates the mechanical responses of cutaneous nociceptors in streptozotocindiabetic rats but not normal rats in vitro. Pain 99: 475-484, 2002.
44. Talbot S, Théberg-Turmel P, Liazogli D, Sénécal J, Gaudreau P, Couture R. Cellular localization of kinin B1 receptor in the spinal cord of streptozotocin- diabetic rats with a fluorescent [Nalpha-Bodipy]-des-Arg9-bradykinin. J Neuroinflammation 16: 11, 2009.
45. Vareniuk I, Pavlov IA, Obrosova IG. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes. Diabetologia 51: 2126-2133, 2008.
46. Wang Z, Dohle C, Friemann J, Green BS, Gleichmann H. Prevention of high- and low-dose STZ-induced diabetes with D-glucose and 5-thio-Dglucose. Diabetes 42: 420-428, 1993.
47. Ziegler D. Painful diabetic neuropathy: advantage of novel drugs over old drugs? Diabetes Care 32, Suppl 2: S414-S419, 2009.
48. Zochodne DW. Is early diabetic neuropathy a disorder of the dorsal root ganglion? A hypothesis and critique of some current ideas on the etiology of diabetic neuropathy. J Periph Nerv Syst 1: 119-130, 1996.